HEPHAISTOS Awarded Best Biotech Pitch at HTID 2025
October 8, 2025 We are delighted to announce that HEPHAISTOS-Pharma…
“Golden Ticket” award for HEPHAISTOS from Amgen France and BioLabs Hôtel-Dieu
December 10th, 2024 HEPHAISTOS-Pharma has the honor to be a…
HEPHAISTOS laureate of the HACKATHON against childhood cancer
November 22th, 2024 HEPHAISTOS-Pharma was laureate of the Hack4Hope, the…
HEPHAISTOS secures €10.3 M to reach the clinical stage
HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a…
Frederic CAROFF will attend BIO Europe Spring in Barcelona
Our CEO, Frederic CAROFF will be attending BIO-Europe Spring 2024…
HEPHAISTOS-Pharma secures a €2 million seed round
HEPHAISTOS-Pharma secures a €2 million seed round with xista science…
HEPHAISTOS Laureate of the SANOFI Golden Ticket mRNA
🏆 We are pleased to announce that HEPHAISTOS-Pharma has…
